Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,954 public trials 1,253 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

NCT02804815

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • Bon Secours Hospital Cork, Ireland
  • Cork University Hospital Cork, Ireland
  • Beaumont Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
View all 82 locations
View Trial Details
Active, Not Recruiting

Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine

NCT05201352

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Centre Georges-François Leclerc Dijon, Bourgogne-Franche-Comté, France
  • CHU Dijon Dijon, Bourgogne-Franche-Comté, France
  • ICO Angers Angers, France
  • Institut Sainte Catherine Avignon, France
View all 14 locations
View Trial Details
Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03821935

Conditions
Adenocarcinoma, Advanced Solid Tumors Cancer, Breast Diseases, +28 more
Locations
  • Highlands Oncology Group, PA /ID# 218942 Springdale, Arkansas, United States
  • City of Hope National Medical Center /ID# 265620 Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center /ID# 270785 Irvine, California, United States
  • Yale University School of Medicine /ID# 208356 New Haven, Connecticut, United States
View all 64 locations
View Trial Details

Related conditions